- Home
- IFS vs ALKS Comparison
IFS vs ALKS Comparison
Compare IFS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFS
- ALKS
- Stock Information
- Founded
- IFS 1897
- ALKS 1987
- Country
- IFS Peru
- ALKS Ireland
- Employees
- IFS N/A
- ALKS N/A
- Industry
- IFS Commercial Banks
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- IFS Finance
- ALKS Health Care
- Exchange
- IFS Nasdaq
- ALKS Nasdaq
- Market Cap
- IFS 4.2B
- ALKS 5.0B
- IPO Year
- IFS 2019
- ALKS 1991
- Fundamental
- Price
- IFS $43.03
- ALKS $30.70
- Analyst Decision
- IFS
- ALKS Strong Buy
- Analyst Count
- IFS 0
- ALKS 13
- Target Price
- IFS N/A
- ALKS $42.31
- AVG Volume (30 Days)
- IFS 174.8K
- ALKS 2.3M
- Earning Date
- IFS 11-06-2025
- ALKS 10-28-2025
- Dividend Yield
- IFS 2.21%
- ALKS N/A
- EPS Growth
- IFS 112.04
- ALKS 2.44
- EPS
- IFS 4.72
- ALKS 2.02
- Revenue
- IFS $1,506,553,476.00
- ALKS $1,521,338,000.00
- Revenue This Year
- IFS N/A
- ALKS N/A
- Revenue Next Year
- IFS $3.48
- ALKS $1.59
- P/E Ratio
- IFS $8.96
- ALKS $15.25
- Revenue Growth
- IFS 39.88
- ALKS 1.08
- 52 Week Low
- IFS $25.77
- ALKS $25.17
- 52 Week High
- IFS $43.34
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- IFS 66.91
- ALKS 52.10
- Support Level
- IFS $41.24
- ALKS $28.47
- Resistance Level
- IFS $42.35
- ALKS $32.11
- Average True Range (ATR)
- IFS 0.76
- ALKS 1.30
- MACD
- IFS 0.22
- ALKS -0.12
- Stochastic Oscillator
- IFS 91.32
- ALKS 56.74
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.